HbA1c (Glycated Hemoglobin)
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
Number of studies
2
Safety
Moderate
Time to effects
The result reflects averaged glycemia from the past 2–3 months — a lifestyle change will only show up in the HbA1c result after several weeks to a few months.
Who it's for
Table of contents
TL;DR
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
- →Reflects average glycemia over 2–3 months, not a single, potentially misleading measurement
- →Doesn't require fasting — can be done at any time of day
- →Detects prediabetes earlier than a single glucose measurement
| Type | Diagnostic biomarker, not an intervention |
|---|---|
| Evidence level | Strong — the gold standard for diagnosing and monitoring diabetes for decades |
| Target group | People with risk factors for type 2 diabetes, people already being treated for diabetes |
| Time to effects | Reflects glycemia from the past 2–3 months, not the current moment |
| Preparation required | None — the test doesn't require fasting |
| Status | Standard diagnostic test |
Understand
Overview
Glycated hemoglobin (HbA1c) forms through the non-enzymatic attachment of glucose to hemoglobin in red blood cells — a process that occurs in proportion to blood glucose concentration throughout the cell's roughly 2–3 month lifespan. This means HbA1c reflects not a momentary but an averaged glycemic level over the past few months, making it a far more stable indicator than a single fasting glucose measurement.
HbA1c is today the primary diagnostic and monitoring tool in diabetes — values below 5.7% are considered normal, 5.7–6.4% indicates prediabetes, and 6.5% or above indicates diabetes (when confirmed by a repeat test). It's precisely this stability over time that has made it the preferred tool for monitoring diabetes treatment worldwide.
Who can this realistically help? People with risk factors for type 2 diabetes (overweight, family history, sedentary lifestyle) — HbA1c detects a developing problem far earlier than a single glucose measurement, which can come back normal despite already-progressing insulin resistance. People with anemia, chronic kidney disease, or hemoglobinopathies should know that these conditions can distort the HbA1c result — in such cases a doctor may recommend additional tests.
Mechanism of action
Glucose circulating in the blood attaches non-enzymatically and irreversibly to hemoglobin molecules inside red blood cells — a process called glycation. The higher the blood glucose concentration over a given period, the greater the proportion of hemoglobin that becomes glycated. Because red blood cells live for about 120 days on average, the HbA1c result reflects a weighted average of glycemia over that period, with the greatest contribution coming from the most recent 30 days.
This property makes HbA1c far less susceptible to momentary fluctuations than a glucose measurement — a single meal, stress, or an infection won't significantly change the result, unlike a fasting glucose measurement, which can come back abnormal for reasons unrelated to long-term glycemic control. The downside of this mechanism is sensitivity to conditions that affect red blood cell lifespan (e.g. hemolytic anemia), which can artificially lower or raise the result regardless of actual glycemia.
Glycation of hemoglobin
Glucose attaches non-enzymatically and irreversibly to hemoglobin molecules in proportion to its blood concentration.
Accumulation over the red blood cell lifecycle
Red blood cells live about 120 days, so the result reflects averaged glycemia over that period.
Greatest weight from the most recent month
Newer red blood cells have had less time to glycate, so the last 30 days weigh most heavily in the final result.
Resistance to momentary fluctuations
A single meal or stressful event doesn't significantly change the result, unlike a single glucose measurement.
Evidence: strong — based on 2 studies in this database.
Benefits
Common myths
MythHbA1c is just another way of measuring blood "sugar" at a given moment.
FactHbA1c measures averaged glycemia over the past 2–3 months, not a momentary glucose level — it's a fundamentally different, more stable indicator.
MythA normal HbA1c result rules out glycemic problems.
FactHbA1c can be falsely lowered by anemia or certain hemoglobinopathies — in such cases a doctor may recommend additional tests, such as fasting glucose.
Practice
Frequently asked questions
Not entirely — both tests provide complementary information. HbA1c shows the long-term trend, while fasting glucose shows the momentary metabolic state.
Because it reflects averaged glycemia over 2–3 months, a noticeable change in the result usually requires at least several weeks to a few months of consistent lifestyle change.
In many countries, including Poland, the test is available commercially without a referral, though it's always worth discussing the result's interpretation with a doctor.
Dosage & timing
Typical dose
Values: below 5.7% normal, 5.7–6.4% prediabetes, 6.5% and above diabetes (when confirmed)
Form
A single blood test, no fasting required
Interpreting diagnostic thresholds should always take the full clinical picture into account and, when in doubt, additional tests (e.g. an oral glucose tolerance test).
Best times to take it
- The test can be done at any time of day, regardless of meals
Safety
Side effects & contraindications
Possible side effects
Not applicable — a diagnostic test, not an intervention
Contraindications
Not directly applicable, but the result may be unreliable with anemia, hemoglobinopathies, or a recent blood transfusion
Interactions
Conditions affecting red blood cell lifespan (hemolytic anemia, chronic kidney disease) can distort the result regardless of actual glycemia
Is it worth taking?
Who it's for
- People with risk factors for type 2 diabetes
- People already being treated for diabetes, monitoring treatment effectiveness
Not for
- Not directly applicable, but the result may be unreliable with anemia, hemoglobinopathies, or a recent blood transfusion
Evidence
Worth knowing
The name HbA1c refers to a specific hemoglobin fraction (A1c) most commonly used to assess glycation.
The formula for converting HbA1c to estimated average glucose (eAG) was published in 2008 based on a large multicenter study.
Studies
Intensive treatment lowering HbA1c significantly reduced the risk of diabetes microvascular complications — retinopathy, nephropathy and neuropathy — in one of the most important studies in the history of diabetology.
Diabetes Control and Complications Trial (DCCT) Research Group, New England Journal of Medicine, 1993
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
Strong evidenceDiabetes Control and Complications Trial (DCCT) Research Group · New England Journal of Medicine · 1993
A landmark study showing that intensive glycemic control (measured in part via HbA1c) significantly reduces the risk of diabetes microvascular complications.
View studyTranslating the A1C Assay Into Estimated Average Glucose Values
Strong evidenceNathan DM, Kuenen J, Borg R, et al. · Diabetes Care · 2008
A study establishing the formula for converting the HbA1c result into estimated average glucose (eAG), making practical interpretation of the result easier.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Medical review
Michał NowakClinical Dietitian
Michał specializes in metabolic nutrition, intermittent fasting and sports supplementation.
61 publications on this site
Related entries
4.6Insulin Resistance
A state in which the body's cells respond more weakly to insulin, forcing the pancreas to produce ever-larger amounts of it — the most common, and largely reversible, precursor of type 2 diabetes.
4.5Metformin
The most commonly prescribed drug for type 2 diabetes in the world — with a well-understood metabolic mechanism and an intensively studied, but still unproven, potential to slow aging.
4.4Low-Glycemic Diet
An eating pattern based on choosing carbohydrates by glycemic index and glycemic load — with solid evidence supporting glycemic control in people with type 2 diabetes and insulin resistance.
4.3Berberine
A plant alkaloid sometimes called 'nature's metformin' — studies show a meaningful effect on blood glucose, though it doesn't replace pharmacological treatment.
4.7Type 2 Diabetes
A chronic metabolic disease in which the body loses its ability to properly regulate blood glucose — and one of the few chronic diseases where a large randomized trial showed that lifestyle change alone can outperform a drug.
4.6Metabolic Syndrome
A cluster of five risk factors — from abdominal obesity to elevated triglycerides — that multiplies the risk of type 2 diabetes and cardiovascular disease, but is largely modifiable through lifestyle change.
4.5Ferritin
An iron-storage protein whose blood level is the best available indicator of the body's iron stores — though it can be falsely elevated by inflammation, which complicates straightforward interpretation.
4.5CRP and hs-CRP
A protein produced by the liver in response to inflammation — in its high-sensitivity form (hs-CRP) it has become one of the most widely studied additional markers of cardiovascular risk.
Related articles
Poradniki5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear
A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.
August 1, 2026
PoradnikiWalking After Meals: How Much Does It Really Lower the Post-Meal Blood Sugar Spike?
"Be active" is advice so general it barely tells you when exactly to move. A randomized clinical trial in people with type 2 diabetes found something far more specific: a short walk right after a meal lowers the post-meal glucose spike more effectively than a generic recommendation to "meet your daily activity target" without specifying timing. What's more, the effect wasn't the same across all meals — after dinner specifically, walking cut the glucose spike by roughly 22%, considerably more than after other meals of the day. This suggests that for blood sugar control, what matters isn't just how much you move over 24 hours, but precisely when you do it. In this article we break down these findings step by step and explain exactly which population they've been shown in.
August 24, 2026
PoradnikiTRT, Diabetes, and Insulin Resistance — Does Testosterone Affect Blood Sugar?
Low testosterone and insulin resistance go together far more often than chance would explain, and testosterone replacement therapy in men with hypogonadism and type 2 diabetes genuinely, though modestly, improves insulin sensitivity — but that's an addition to diabetes treatment, not a replacement for it.
August 15, 2026
PoradnikiBerberine vs. Metformin: Does "Nature's Metformin" Really Measure Up?
"Nature's metformin" is one of the most repeated slogans in supplementation — and, surprisingly, one of the rare cases where a direct comparison with the drug actually exists. We check what that comparison really showed, how solid the 46-trial meta-analysis behind it is, and what popular headlines don't say about side effects.
August 22, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.